MedKoo Cat#: 581902 | Name: Ethyl 5-hydroxydecanoate

Description:

WARNING: This product is for research use only, not for human or veterinary use.

Ethyl 5-hydroxydecanoate is flavor and Fragrance Chemical Compounds.

Chemical Structure

Ethyl 5-hydroxydecanoate
Ethyl 5-hydroxydecanoate
CAS#75587-06-3

Theoretical Analysis

MedKoo Cat#: 581902

Name: Ethyl 5-hydroxydecanoate

CAS#: 75587-06-3

Chemical Formula: C12H24O3

Exact Mass: 216.1725

Molecular Weight: 216.32

Elemental Analysis: C, 66.63; H, 11.18; O, 22.19

Price and Availability

This product is currently not in stock but may be available through custom synthesis. To ensure cost efficiency, the minimum order quantity is 1 gram. The estimated lead time is 2 to 4 months, with pricing dependent on the complexity of the synthesis (typically high for intricate chemistries). Quotes for quantities below 1 gram will not be provided. To request a quote, please click the button below. Note: If this product becomes available in stock in the future, pricing will be listed accordingly.
Bulk Inquiry
Related CAS #
No Data
Synonym
Ethyl 5-hydroxydecanoate; (+-)-Ethyl 5-hydroxydecanoate; 5-Hydroxydecanoic acid ethyl ester; Decanoic acid, 5-hydroxy-, ethyl ester; Ethyl 5-hydroxydecanoate, (+-)-.
IUPAC/Chemical Name
5-Hydroxydecanoic acid ethyl ester
InChi Key
JZHPHZPSKLWKPM-UHFFFAOYSA-N
InChi Code
InChI=1S/C12H24O3/c1-3-5-6-8-11(13)9-7-10-12(14)15-4-2/h11,13H,3-10H2,1-2H3
SMILES Code
CCCCCC(O)CCCC(OCC)=O
Appearance
Solid powder
Purity
>98% (or refer to the Certificate of Analysis)
Shipping Condition
Shipped under ambient temperature as non-hazardous chemical. This product is stable enough for a few weeks during ordinary shipping and time spent in Customs.
Storage Condition
Dry, dark and at 0 - 4 C for short term (days to weeks) or -20 C for long term (months to years).
Solubility
Soluble in DMSO
Shelf Life
>3 years if stored properly
Drug Formulation
This drug may be formulated in DMSO
Stock Solution Storage
0 - 4 C for short term (days to weeks), or -20 C for long term (months).
HS Tariff Code
2934.99.9001
More Info

Preparing Stock Solutions

The following data is based on the product molecular weight 216.32 Batch specific molecular weights may vary from batch to batch due to the degree of hydration, which will affect the solvent volumes required to prepare stock solutions.

Recalculate based on batch purity %
Concentration / Solvent Volume / Mass 1 mg 5 mg 10 mg
1 mM 1.15 mL 5.76 mL 11.51 mL
5 mM 0.23 mL 1.15 mL 2.3 mL
10 mM 0.12 mL 0.58 mL 1.15 mL
50 mM 0.02 mL 0.12 mL 0.23 mL
1: Selvarajan R, Sibanda T, Tekere M, Nyoni H, Meddows-Taylor S. Diversity Analysis and Bioresource Characterization of Halophilic Bacteria Isolated from a South African Saltpan. Molecules. 2017 Apr 20;22(4). pii: E657. doi: 10.3390/molecules22040657. PubMed PMID: 28425950; PubMed Central PMCID: PMC6154464. 2: Liang W, Chen M, Zheng D, Li J, Song M, Zhang W, Feng J, Lan J. The Opening of ATP-Sensitive K+ Channels Protects H9c2 Cardiac Cells Against the High Glucose-Induced Injury and Inflammation by Inhibiting the ROS-TLR4-Necroptosis Pathway. Cell Physiol Biochem. 2017;41(3):1020-1034. doi: 10.1159/000461391. Epub 2017 Feb 22. PubMed PMID: 28291959. 3: Jin C, Wu J, Watanabe M, Okada T, Iesaki T. Mitochondrial K+ channels are involved in ischemic postconditioning in rat hearts. J Physiol Sci. 2012 Jul;62(4):325-32. doi: 10.1007/s12576-012-0206-y. Epub 2012 Apr 19. PubMed PMID: 22528048. 4: Gross GJ, Hsu A, Gross ER, Falck JR, Nithipatikom K. Factors mediating remote preconditioning of trauma in the rat heart: central role of the cytochrome p450 epoxygenase pathway in mediating infarct size reduction. J Cardiovasc Pharmacol Ther. 2013 Jan;18(1):38-45. doi: 10.1177/1074248412437586. Epub 2012 Mar 9. PubMed PMID: 22407888; PubMed Central PMCID: PMC3449041. 5: Routhu KV, Tsopanoglou NE, Strande JL. Parstatin(1-26): the putative signal peptide of protease-activated receptor 1 confers potent protection from myocardial ischemia-reperfusion injury. J Pharmacol Exp Ther. 2010 Mar;332(3):898-905. doi: 10.1124/jpet.109.162602. Epub 2009 Dec 15. PubMed PMID: 20008957. 6: Strande JL, Hsu A, Su J, Fu X, Gross GJ, Baker JE. Inhibiting protease-activated receptor 4 limits myocardial ischemia/reperfusion injury in rat hearts by unmasking adenosine signaling. J Pharmacol Exp Ther. 2008 Mar;324(3):1045-54. Epub 2007 Nov 30. PubMed PMID: 18055876; PubMed Central PMCID: PMC2935083. 7: Jang Y, Wang H, Xi J, Mueller RA, Norfleet EA, Xu Z. NO mobilizes intracellular Zn2+ via cGMP/PKG signaling pathway and prevents mitochondrial oxidant damage in cardiomyocytes. Cardiovasc Res. 2007 Jul 15;75(2):426-33. Epub 2007 May 17. PubMed PMID: 17570352; PubMed Central PMCID: PMC1986796. 8: Xia Y, Javadov S, Gan TX, Pang T, Cook MA, Karmazyn M. Distinct KATP channels mediate the antihypertrophic effects of adenosine receptor activation in neonatal rat ventricular myocytes. J Pharmacol Exp Ther. 2007 Jan;320(1):14-21. Epub 2006 Sep 29. PubMed PMID: 17012605. 9: Bian JS, Yong QC, Pan TT, Feng ZN, Ali MY, Zhou S, Moore PK. Role of hydrogen sulfide in the cardioprotection caused by ischemic preconditioning in the rat heart and cardiac myocytes. J Pharmacol Exp Ther. 2006 Feb;316(2):670-8. Epub 2005 Oct 4. PubMed PMID: 16204473. 10: Philipp S, Cui L, Ludolph B, Kelm M, Schulz R, Cohen MV, Downey JM. Desferoxamine and ethyl-3,4-dihydroxybenzoate protect myocardium by activating NOS and generating mitochondrial ROS. Am J Physiol Heart Circ Physiol. 2006 Jan;290(1):H450-7. Epub 2005 Sep 9. PubMed PMID: 16155105. 11: Busija DW, Katakam P, Rajapakse NC, Kis B, Grover G, Domoki F, Bari F. Effects of ATP-sensitive potassium channel activators diazoxide and BMS-191095 on membrane potential and reactive oxygen species production in isolated piglet mitochondria. Brain Res Bull. 2005 Jul 30;66(2):85-90. PubMed PMID: 15982523. 12: Das B, Sarkar C. Is the sarcolemmal or mitochondrial K(ATP) channel activation important in the antiarrhythmic and cardioprotective effects during acute ischemia/reperfusion in the intact anesthetized rabbit model? Life Sci. 2005 Jul 29;77(11):1226-48. PubMed PMID: 15964023. 13: Moon CH, Kim MY, Kim MJ, Kim MH, Lee S, Yi KY, Yoo SE, Lee DH, Lim H, Kim HS, Lee SH, Baik EJ, Jung YS. KR-31378, a novel benzopyran analog, attenuates hypoxia-induced cell death via mitochondrial KATP channel and protein kinase C-epsilon in heart-derived H9c2 cells. Eur J Pharmacol. 2004 Dec 3;506(1):27-35. PubMed PMID: 15588621. 14: Fischbach PS, White A, Barrett TD, Lucchesi BR. Risk of ventricular proarrhythmia with selective opening of the myocardial sarcolemmal versus mitochondrial ATP-gated potassium channel. J Pharmacol Exp Ther. 2004 May;309(2):554-9. Epub 2004 Jan 27. PubMed PMID: 14747611. 15: Das B, Sarkar C. Cardiomyocyte mitochondrial KATP channels participate in the antiarrhythmic and antiinfarct effects of KATP activators during ischemia and reperfusion in an intact anesthetized rabbit model. Pol J Pharmacol. 2003 Sep-Oct;55(5):771-86. PubMed PMID: 14704474. 16: Jones SP, Teshima Y, Akao M, Marbán E. Simvastatin attenuates oxidant-induced mitochondrial dysfunction in cardiac myocytes. Circ Res. 2003 Oct 17;93(8):697-9. Epub 2003 Sep 25. PubMed PMID: 14512440. 17: de Klaver MJ, Buckingham MG, Rich GF. Lidocaine attenuates cytokine-induced cell injury in endothelial and vascular smooth muscle cells. Anesth Analg. 2003 Aug;97(2):465-70, table of contents. PubMed PMID: 12873936. 18: Jung YS, Jung YS, Kim MY, Kim MH, Lee S, Yi KY, Yoo SE, Lee SH, Baik EJ, Moon CH, Cho JP. KR-31466, a benzopyranylindol analog, attenuates hypoxic injury through mitochondrial K(ATP) channel and protein kinase C activation in heart-derived H9c2 cells. J Pharmacol Sci. 2003 May;92(1):13-8. PubMed PMID: 12832850. 19: Lee S, Yi KY, Kim SK, Suh J, Kim NJ, Yoo SE, Lee BH, Seo HW, Kim SO, Lim H. Cardioselective anti-ischemic ATP-sensitive potassium channel (KATP) openers: benzopyranyl indoline and indole analogues. Eur J Med Chem. 2003 May;38(5):459-71. PubMed PMID: 12767596. 20: Das B, Sarkar C. Mitochondrial K ATP channel activation is important in the antiarrhythmic and cardioprotective effects of non-hypotensive doses of nicorandil and cromakalim during ischemia/reperfusion: a study in an intact anesthetized rabbit model. Pharmacol Res. 2003 Jun;47(6):447-61. PubMed PMID: 12741997.